Log In
Print
BCIQ
Print
Print this Print this
 

MEDI-559

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionLive attenuated respiratory syncytial virus (RSV) vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent severe respiratory syncytial virus (RSV) infections in children
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today